The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Drapkina O.M.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Klinika propedevtiki vnutrennikh bolezneĭ, gastroénterologii i gepatologii

Samorodskaia I.V.

FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava Rossii, Moskva

Larina V.N.

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia

Luk'ianov M.M.

FGBU "GNITs profilakticheskoĭ meditsiny" Minzdrava RF, Moskva

The issues of organization of care for patients with multimorbidity: an analytic review of international and Russian guidelines

Authors:

Drapkina O.M., Samorodskaia I.V., Larina V.N., Luk'ianov M.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2019;22(2): 107‑114

Read: 2211 times


To cite this article:

Drapkina OM, Samorodskaia IV, Larina VN, Luk'ianov MM. The issues of organization of care for patients with multimorbidity: an analytic review of international and Russian guidelines. Russian Journal of Preventive Medicine. 2019;22(2):107‑114. (In Russ.)
https://doi.org/10.17116/profmed201922021107

Recommended articles:
Physician and patients’ views on tele­medicine technologies. Russian Journal of Preventive Medi­cine. 2025;(1):37-43

References:

  1. Piepoli MF, Hoes AW, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016. https://doi.org/10.1093/eurheartj/ehw106
  2. Boytsov SA, Pogosova NA, Bubnova MG, Drapkina OM, et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;6(23):7-122. (In Russ.)
  3. Arnett DA, Goodman RA, Halperin JL, et al. AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients with Cardiovascular Disease and Comorbid Conditions. Circulation. 2014;130:1662-1667. https://doi.org/10.1161/CIR.0000000000000128
  4. Moffat K, Mercer S. BMC Family Practice. 2015;16:129. https://doi.org/10.1186/s12875-015-0344-4
  5. Smith S, Soubhi H, Fortin M, Hudon C, O’Dowd T. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ. 2012;345:e5205.
  6. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, et al. Prevalence, Determinants and Patterns of Multimorbidity in Primary Care: A Systematic Review of Observational Studies. PLoS ONE. 2014;9(7):e102149. https://doi.org/10.1371/journal.pone.0102149
  7. Huntley A, Johnson R, Purdy S, Valderas J, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. 2012;10:134-141.
  8. France E, Wyke S, Gunn J, Mair F, McLean G, et al. Multimorbidity in primary care: a systematic review of prospective cohort studies. Br J Gen Pract. 2012;62:e297-e307.
  9. Mondor L, Maxwell C, Hogan D, et al. Multimorbidity and healthcare utilization among home care clients with dementia in Ontario, Canada: a retrospective analysis of a population-based cohort. PLoS Med. 2017;14: e1002249. https://doi.org/10.1371/journal.pmed.1002249
  10. Bowling C, Plantinga L, Phillips L, et al. Association of multimorbidity with mortality and healthcare utilization in chronic kidney disease. J Am Geriatr Soc. 2016;65:704-711. https://doi.org/10.1111/jgs.14662
  11. Geersing G, de Groot J, Reitsma J, Hoes A, Rutten F. The impending epidemic of chronic cardiopulmonary disease and multimorbidity: the need for new research approaches to guide daily practice. Chest. 2015;148:865-869. https://doi.org/10.1378/chest.14-3172
  12. Duncan P, Murphy M, Man M, et al. Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ). BMJ Open. 2018;8(4):e019413.
  13. Prados-Torres A, Poblador-Plou B, Gimeno-Miguel A, et al. Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study. 2018;47(2):382-384f. https://doi.org/10.1093/ije/dyx259
  14. Parekh A, Goodman R, Gordon C, Koh H. HHS Interagency Workgroup on Multiple Chronic Conditions. Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life. Public Health Rep. 2011;126:460-471. https://doi.org/10.1177/003335491112600403
  15. American Geriatrics Society Expert Panel on the Care of Older Adults with M. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc. 2012;60:E1-E25. https://doi.org/10.1111/j.1532-5415.2012.04188.x
  16. Leppin L, Montori V, Gionfriddo M. Minimally disruptive medicine: a pragmatically comprehensive model for delivering care to patients with multiple chronic conditions. Healthcare (Basel). 2015;3:50-63. https://doi.org/10.3390/healthcare3010050
  17. Muth C, van den Akker M, Blom J, et al. The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med. 2014;12:223. https://doi.org/10.1186/s12916-014-0223-1
  18. National Guideline Centre. Multimorbidity: clinical assessment and management. London (UK): National Institute for Health and Care Excellence. NICE. 2016;23. (NICE guideline; no. 56).
  19. Palmer K, Marengoni A, Forjaz M, et al. Multimorbidity care model: recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). Health Policy. 2018;122(1):4-11. https://doi.org/10.1016/j.healthpol.2017.09.006
  20. Oganov RG, Denisov IN, Simanenkov VI, et al. Comorbidities in practice. Clinical Guidelines. Cardiovascular Therapy and Prevention. 2017;16(6). (In Russ.) https://doi.org/10.15829/1728-8800-2017-6
  21. Pathirana T, Jackson C. Socioeconomic status and multimorbidity: a systematic review and metaanalysis. Aust NZ J Public Health. Online. 2018. https://doi.org/10.1111/1753-6405.12762
  22. Marengoni A, Pasina L, Concoreggi C, et al. Understanding adverse drug reactions in older adults through drug-drug interactions. Eur J Intern Med. 2014;25:843-846. https://doi.org/10.1016/j.ejim.2014.10.001
  23. Marengoni A, Onder G. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ. (Clinical research). 2015;350: h1059. https://doi.org/10.1136/bmj.h1059
  24. McManus R, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, Bradburn P, Farmer A, Grant S, Greenfield S, et al. on behalf of the TASMINH4 investigators. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomized controlled trial. Lancet. 2018;391:949-959. https://doi.org/10.1016/S0140-6736(18)30309-X
  25. Cowie M, Bax J, Bruining N, Cleland J, Koehler F, Malik M, Pinto F, van der Velde E, Vardas P. Health: a position statement of the European Society of Cardiology. Eur Heart J. 2016;37:63-66. https://doi.org/10.1093/eurheartj/ehv416
  26. Mair F, May C. Thinking about the burden of treatment. BMJ. 2014;349: g6680.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.